[go: up one dir, main page]

PT4112063T - Métodos e tratamento de trauma - Google Patents

Métodos e tratamento de trauma

Info

Publication number
PT4112063T
PT4112063T PT221914773T PT22191477T PT4112063T PT 4112063 T PT4112063 T PT 4112063T PT 221914773 T PT221914773 T PT 221914773T PT 22191477 T PT22191477 T PT 22191477T PT 4112063 T PT4112063 T PT 4112063T
Authority
PT
Portugal
Prior art keywords
trauma
treatment
methods
Prior art date
Application number
PT221914773T
Other languages
English (en)
Original Assignee
Hemanext Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemanext Inc filed Critical Hemanext Inc
Publication of PT4112063T publication Critical patent/PT4112063T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
PT221914773T 2017-05-19 2018-05-18 Métodos e tratamento de trauma PT4112063T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762508783P 2017-05-19 2017-05-19

Publications (1)

Publication Number Publication Date
PT4112063T true PT4112063T (pt) 2025-01-27

Family

ID=62528888

Family Applications (3)

Application Number Title Priority Date Filing Date
PT221914773T PT4112063T (pt) 2017-05-19 2018-05-18 Métodos e tratamento de trauma
PT201732047T PT3708174T (pt) 2017-05-19 2018-05-18 Métodos e tratamento de trauma
PT187292883T PT3624812T (pt) 2017-05-19 2018-05-18 Métodos e tratamento de trauma

Family Applications After (2)

Application Number Title Priority Date Filing Date
PT201732047T PT3708174T (pt) 2017-05-19 2018-05-18 Métodos e tratamento de trauma
PT187292883T PT3624812T (pt) 2017-05-19 2018-05-18 Métodos e tratamento de trauma

Country Status (13)

Country Link
US (7) US11026970B2 (pt)
EP (4) EP4112063B1 (pt)
JP (3) JP2020520937A (pt)
CN (1) CN110636850A (pt)
AU (2) AU2018270096B2 (pt)
BR (1) BR112019024249A2 (pt)
CA (1) CA3063445A1 (pt)
ES (3) ES2931228T3 (pt)
IL (2) IL270534B2 (pt)
MX (2) MX2019013785A (pt)
PT (3) PT4112063T (pt)
WO (1) WO2018213714A1 (pt)
ZA (1) ZA202211980B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2931228T3 (es) 2017-05-19 2022-12-27 Hemanext Inc Procedimientos y tratamiento de traumatismos
US12447177B2 (en) * 2018-11-16 2025-10-21 Hemanext Inc. Methods for managing adverse events in patients with inflammation
WO2024064723A1 (en) * 2022-09-20 2024-03-28 Hemanext Inc. Oxygen reduced blood for use in the treatment of traumatic brain injury accompanied by hemorrhagic shock

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6447987B1 (en) 1978-09-09 2002-09-10 The United States Of America As Represented By The Secretary Of The Army Prolonged storage of red blood cells
US4769318A (en) 1986-06-03 1988-09-06 Ube Industries, Ltd. Additive solution for blood preservation and activation
US4880786A (en) 1987-01-14 1989-11-14 Ube Industries, Ltd. Additive solution for blood preservation and activation
US5476764A (en) 1994-09-16 1995-12-19 The Regents Of The University Of California Method using CO for extending the useful shelf-life of refrigerated red blood cells
US5624794A (en) 1995-06-05 1997-04-29 The Regents Of The University Of California Method for extending the useful shelf-life of refrigerated red blood cells by flushing with inert gas
US6162396A (en) 1997-04-26 2000-12-19 The Regents Of The University Of California Blood storage device and method for oxygen removal
US5789151A (en) 1997-05-15 1998-08-04 The Regents Of The University Of California Prolonged cold storage of red blood cells by oxygen removal and additive usage
US6413713B1 (en) 1998-10-30 2002-07-02 Hyperbaric Systems Method for preserving blood platelets
WO2008100140A1 (en) * 2007-02-12 2008-08-21 Biotempt B.V. Treatment of trauma hemorrhage with short oligopeptides
SI2440239T1 (en) * 2009-06-09 2018-01-31 Prolong Pharmaceuticals, LLC Hemoglobin compositions
US9067004B2 (en) * 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
ES2941907T3 (es) * 2011-07-05 2023-05-26 Hemanext Inc Procedimiento para el almacenamiento prolongado de glóbulos rojos
CN107530377B (zh) * 2015-03-10 2021-09-03 新健康科学股份有限公司 氧减少一次性套件、装置及其使用方法
EP3297641B1 (en) * 2015-05-18 2025-07-09 Hemanext Inc. Methods for the storage of whole blood, and compositions thereof
US10335538B2 (en) * 2015-12-08 2019-07-02 Priya Visweswaran Balakrishnan System and treatment method to increase circulation and pluripotency of stem and progenitor cells within a patient
PT3463466T (pt) * 2016-05-27 2022-04-04 Hemanext Inc Método de armazenamento de sangue anaeróbio e inativação de patógenos
EP4321215A3 (en) * 2016-06-23 2024-04-17 Hemanext Inc. Methods for managing adverse events in patient populations requiring transfusion
ES2931228T3 (es) * 2017-05-19 2022-12-27 Hemanext Inc Procedimientos y tratamiento de traumatismos

Also Published As

Publication number Publication date
CN110636850A (zh) 2019-12-31
JP2020520937A (ja) 2020-07-16
ES2931228T3 (es) 2022-12-27
CA3063445A1 (en) 2018-11-22
EP4470616A2 (en) 2024-12-04
WO2018213714A1 (en) 2018-11-22
EP4470616A3 (en) 2025-02-26
US20210030790A1 (en) 2021-02-04
EP3708174B1 (en) 2022-10-12
US11026970B2 (en) 2021-06-08
US20200197438A1 (en) 2020-06-25
ES3007157T3 (en) 2025-03-19
IL270534B2 (en) 2024-10-01
IL312474A (en) 2024-06-01
US20200237818A1 (en) 2020-07-30
US20210290669A1 (en) 2021-09-23
PT3708174T (pt) 2023-01-16
BR112019024249A2 (pt) 2020-06-02
MX2025003895A (es) 2025-05-02
US10898517B2 (en) 2021-01-26
IL270534A (pt) 2020-01-30
ES2935691T3 (es) 2023-03-09
US11026971B2 (en) 2021-06-08
EP3624812A1 (en) 2020-03-25
US20200376027A1 (en) 2020-12-03
EP3708174A1 (en) 2020-09-16
AU2018270096B2 (en) 2025-01-16
JP2025106261A (ja) 2025-07-15
AU2018270096A1 (en) 2019-11-28
US11033581B2 (en) 2021-06-15
IL270534B1 (en) 2024-06-01
ZA202211980B (en) 2024-05-30
EP4112063B1 (en) 2024-10-23
US11576931B2 (en) 2023-02-14
JP2023063294A (ja) 2023-05-09
US20230165896A1 (en) 2023-06-01
EP4112063A1 (en) 2023-01-04
US20200179446A1 (en) 2020-06-11
AU2024278573A1 (en) 2025-01-09
PT3624812T (pt) 2022-11-30
EP3624812B1 (en) 2022-08-24
US11052110B2 (en) 2021-07-06
MX2019013785A (es) 2020-01-13
US20220118008A9 (en) 2022-04-21

Similar Documents

Publication Publication Date Title
ZA202006746B (en) Methods of treatment
EP3256152A4 (en) Treatment of bone fractures and defects
IL264451B1 (en) A combination of abt-199 and achmetalstat for the treatment of aml
ZA201907401B (en) Treatment of adipocytes
EP3684342C0 (en) TREATMENT PROCEDURES
PL3183003T3 (pl) SPOSOBY ZAPOBIEGANIA l/LUB LECZENIA ZAKAŻENIA
GB201815588D0 (en) Method of treatment
EP3134108A4 (en) Agents and methods of treatment
GB201706406D0 (en) Method of treatment
EP3654958A4 (en) METHODS OF PATIENT SELECTION AND TREATMENT OF TRXR OR PRDX OVEREXPRESSING CANCERS
GB201511799D0 (en) Composition and methods of treatment
PT3624812T (pt) Métodos e tratamento de trauma
SG11202005850VA (en) Methods of treatment of hypertrigl yceridemia
EP3691748A4 (en) ACETAMINOPHEN-PREGABALIN COMBINATIONS AND METHODS OF TREATMENT OF PAIN
GB201621737D0 (en) Compositions and methods of treatment
GB201605127D0 (en) Composition and methods of treatment
IL271727A (en) Method of treatment and their dosage forms
GB201710491D0 (en) Composition and methods of treatment
GB201503371D0 (en) Methods of screening and treatment
GB201815000D0 (en) Treatment of hypothroidism and related conditions
HK40038038A (en) Methods of treatment of hypertrigl yceridemia
HK40027634A (en) Methods and devices for the treatment of food allergies
GB201810925D0 (en) Compositions and methods of treatment
AU2017904756A0 (en) Pharmaceutical combinations and methods of treatment
GB201801249D0 (en) Methods of treatment